我們已在上線! 進一步了解
LHDX

Lucira Health, Inc. Common Stock

已下市

LHDX已於2023年3月3日下市。

 

關於: Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. It has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fit in the palm of a hand. The company's initial focus is within respiratory diseases, and initially for COVID-19 and influenza Types A and B indications.

員工: 221

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於LHDX的最新新聞文章。

價格圖表採用Lightweight Charts™實作